![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 16/32 | (2006.01) |
C07K 16/06 | (2006.01) | ||
C07K 1/18 | (2006.01) | ||
A61K 39/395 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 2238172 |
(13) | Kind of document | T |
(96) | European patent application number | 09709065.8 |
Date of filing the European patent application | 2009-01-28 | |
(97) | Date of publication of the European application | 2010-10-13 |
(45) | Date of publication and mention of the grant of the patent | 2018-02-21 |
(46) | Date of publication of the claims translation | 2018-05-10 |
(86) | Number | PCT/US2009/032220 |
Date | 2009-01-28 |
(87) | Number | WO 2009/099829 |
Date | 2009-08-13 |
(30) | Number | Date | Country code |
24825 P | 2008-01-30 | US |
(72) |
HARRIS, Reed, J., US
MOTCHNIK, Paul, A., US
|
(73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
(74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Kompozicija, apimanti antikūną, kuris rišasi prie HER-2 domeno II ir rūgštinių jo variantų |
COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF |
Payment date | Validity (years) | Amount | |
2024-12-18 | 17 | 347.00 EUR |
2026-01-28 |